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Scenario 2: Chronic Obstructive Pulmonary Disease (COPD) 
 
Section 1: Pathology of COPD 
 
Introduction 
You now have a good foundation of knowledge regarding the cardiovascular 
respiratory system.  With this knowledge of normal anatomy and physiology as well 
as the effects of asthma on the lung tissues you can begin to clinically reason how 
different diseases of the lung can affect the respiratory system. 
 
In this workbook we will be looking at COPD and considering the signs and 
symptoms that your patients may present. You will already have been introduced to 
COPD and its effect on a person as well as the family unit in your trigger. 
Considering your patient holistically is vital and this will become more evident as you 
proceed through week two of the cardiovascular unit.  
 
Where to start? 
Having knowledge of the pathology of COPD will help you to develop your clinical 
reasoning, so it is recommended that you begin by completing activity 1.  
 
Intended Learning Outcomes (ILOs) 
Please refer to the ILOs for the cardio-vascular respiratory unit which can be found in 
your level I unit guide, page 8. Each section in this workbook is designed to help you 
meet those ILO’s, which have been outlined below; 
 
Section 1: Pathology of COPD 
When you have worked through section 1 you’ll be able to describe the causes, tests 
and diagnosis of COPD and it’s effect on normal lung tissue   
 
Section 2: Management of COPD 
When you have worked through section 2 you’ll be able to list the medication and 
method of application used to control COPD 
 
Section 3: Pulmonary rehabilitation 
When you have worked through section 3 you’ll be able to list different outcome 
measures and discuss the role of the multi-disciplinary team (MDT) 
 
Section 4: CPAP / BiPAP 
When you have worked through section 4 you’ll be able to state when CPAP and 
BiPAP should be administered 
 
Section 5: Psychosocial 
When you have worked through section 5 you’ll be able to identify problems with your 
patient’s mobility and functional impairment due to psychosocial aspects of their well-
being. 
 
Section 6: Case study 
When you have worked through section 6 you’ll be able to clinically reason a 
treatment plan using SMART (specific, measurable, achievable, realistic, time-based) 
goals using evidence-based practice (EBP) 
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 Activity 1 (one and a half hours): Using either Hough (2001) or Pryor and 
Prasad (2004) read about the pathology of COPD and fill in the gaps to 
test your knowledge on the definition, causes, tests and diagnosis of 
COPD. 
 
 
 
COPD means -----------------  ------------------------  -------------------------  -------------
------and includes two respiratory disorders ------------------------- and --------------
-----------------------. These two disorders cause ------------------------------------------
-and commonly occur together. ---------------------------- causes inflammation of 
the bronchi while ------------------------------------causes damage to the small 
airways and ---------------------------- which leads to --------------------------------- 
where there is a loss in the surface area reducing gaseous exchange. 
 
 
The main cause of COPD is ----------------------------------------, but -------------------
---------------------- can also be a contributing factor. Chronic is defined as--------
-------------------------and obstruction is caused by---------------------------------------. 
Pulmonary is a term meaning ---------------------------------------------.  
 
 
COPD and asthma have similar symptoms but they are very different 
diseases. In COPD the damage to the airways is -------------------------------- 
whereas in asthma it is  -------------------------------. It is important to remember 
that some people with COPD also have asthma. In order to confirm the 
diagnosis of COPD a ----------------------------------- test is carried out. This test 
measures ------------------------------ and with a result of a ------------------------- 
value combined with four typical symptoms of COPD 1.------------------------------
----------2,--------------------------------------3,------------------------------------------------
4,----------------------------------- confirms the diagnosis of COPD.  
 
 
Symptoms usually begin at the age of ------------------------------- after smoking 
for -------years or more. There is usually a gradual ------------------------ over the 
years with a --------------------------- cough, and increased --------------------------. 
Chest infections become more frequent and there is often an increase of 
symptoms which is known as an ----------------------------------------------. As the 
disease becomes more severe there is a lack of ---------------------------------- to 
the lungs due to the ------------------------. This in turn decreases the amount of -
----------------------entering the blood stream, which can lead to ----------------------
---------------------. 
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Activity 2 (30 mins): As you have discovered from your learning, COPD 
is a combination of bronchitis and emphysema, so lets now look at 
these two pathologies separately to consolidate your learning by 
completing part 1 and part 2. Remember there may also be elements of 
asthma so don’t forget what you learnt in week 1! 
 
Part 1: Consider what happens to normal lung tissue when Bronchitis is 
present 
  
Describe what you see happening to the lung tissue in the above diagram. 
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------- 
 
What are the symptoms of Bronchitis?  
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------- 
 
How long does Bronchitis normally last for? 
-------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------- 
 
What happens if the secretions (phlegm) are not removed from the lung 
tissues? --------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------- 
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Part 2: Consider what happens to normal lung tissue when emphysema is 
present 
    Describe what happens to the alveoli in the lung tissue 
of someone with emphysema. 
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------- 
 
 
  
Why do people with emphysema become short of breath? 
 
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------- 
 
 
 
Describe how and why the chest shape changes? 
 
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------- 
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 Section 2: Management of COPD 
 
In this section we will be drawing upon your previous 
knowledge of skills techniques taught in week 1 of the cardiovascular respiratory unit. 
This section will help you to apply those techniques to practice.  
 
You have been taught “percussions” and “vibrations” as two-hands-on physiotherapy 
techniques, which can be used to remove secretions from the lungs. These 
techniques cause movements within the lung tissues and help to dislodge the 
secretions that are ‘stuck’ in the airways. The latter enables the patient to cough the 
secretions out of the lungs more efficiently. This can be enhanced by positioning the 
patient according to where the secretions are. Your stethoscope will provide you with 
this information as well as helping you to diagnose your patient’s condition.  
 
At this stage we expect you to practice listening to ‘normal’ lungs not only in skills 
sessions but at every opportunity you have. This skill comes with practice. A CD Rom 
is available to help you to learn different sounds and their diagnosis and you will be 
introduced to this in your skills sessions. Please take the opportunity to listen to this 
at regular intervals throughout the unit. 
 
COPD patients will be on certain medications to help ease their symptoms. As 
physiotherapists it is paramount that you understand what each medication does and 
how it helps in the management of COPD. With this knowledge you will be able to 
time your treatment accordingly so that your manual skills will be effective and 
beneficial for your patient. Knowing when and when not to carry out your 
physiotherapy treatment, is vital in maintaining compliance and preventing your 
patients from discomfort and increased breathlessness. 
 
Following reading ‘Drug therapy’ page 133 to 144 in Hough (2001) complete the 
multiple-choice questionnaire on the following page to test your knowledge in this 
subject.  
 
Using the skills learnt from CARP find the following articles to help you to link 
evidence based practice (EBP) to your COPD management. 
 
1. Shrestha. M, O'Brien. T, Haddox. R., 1991. Decreased duration of emergency 
department treatment of chronic obstructive pulmonary disease exacerbations 
with the addition of ipratropium bromide to beta-agonist therapy Ann Emerg 
Med. 20:1206-9 
2. Moayyedi. P, Conglton. J, Page. R L., 1995. Comparison of nebulised 
salbutamol and ipratropium bromide with salbutamol alone in the treatment of 
chronic obstructive pulmonary disease Thorax. 50:834-7 
3. Koutsogiannis. Z, Kelly. A M., 2000. Does high dose ipratropium bromide 
added to salbutamol improve pulmonary function for patients with chronic 
obstructive airways disease in the emergency department? Aus New Zealand 
Med J. 30:38-40.  
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 Activity 3 (30 mins): Complete the multiple choice questionnaire on the 
medication used to treat COPD 
1. Bronchodilators 
a) Open your airways 
b) Close your airways 
c) Narrow your airways 
d) Block your airways 
 
2. Bronchodilators are administered by 
a) Liquid 
b) Pills 
c) Inhalers 
d) All of the above 
 
3. Beta-antagonist are 
a) Steroids 
b) Bronchodilators 
c) Anti-biotics 
d) None of the above 
 
4. Anti-cholenergics are 
a) Steroids 
b) Bronchodilators 
c) Anti-biotics 
d) None of the above 
 
5. Beta-antagonists work by 
a) Relaxing the muscles around the airways 
b) Increasing the blood flow to the muscles around the airways 
c) Reducing the inflammation in the muscles around the airways 
d) Decreasing the blood flow to the muscles around the airways 
 
6. The most common side-effect of beta-antagonist is 
a) Nausea 
b) Fatigue 
c) Muscle tremor 
d) Cramp 
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7. Anti-cholonergics work by 
a) Contracting the muscles around the airways 
b) Blocking the chemical which our bodies produce preventing 
inflammation 
c) Relaxing the muscles around the airways 
d) Blocking the chemical produced by our bodies that normally 
causes the airways to contract 
 
8. Steroids work by 
a) Reducing muscle contraction in the airways 
b) Increasing the blood flow to the airways  
c) Reducing secretions and inflammation in the airways 
d) None of the above 
 
9. Anti-biotics are necessary to 
a) Protect the lungs 
b) Prevent infections 
c) Reduce inflammation 
d) Prevent inflammation 
 
10. Oxygen is required when the patient is 
a) Breathless 
b) Fatigued 
c) Experiencing increased heart rate, increased respiratory rate 
and confusion 
d) Hyperventilating (breathing at speed) 
 
Well done you now have a base-line knowledge of the medication used 
to control COPD. 
Activity 4 (10 mins): To help you to comprehend and search for 
medication that your patients may be on, subscribe to the on-line British 
National Formulary (BNF) which is available at 
www.bnf.org/bnf/registration  and is free of charge. 
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 Activity 5 (40 mins):
 
To build on your knowledge of COPD medication 
find out the following; 
Name four commonly used steroidal drugs 
1. ----------------------------------------------------- 
2. ----------------------------------------------------- 
3. ------------------------------------------------------ 
4. ------------------------------------------------------ 
List four ways of administering medication for airway obstruction 
1. ----------------------------------------------------- 
2. ----------------------------------------------------- 
3. ----------------------------------------------------- 
4. ----------------------------------------------------- 
Name the device used to help prevent oral thrush (fungal infection of the 
mouth) 
----------------------------------------------------------- 
List three side effects of corticosteroids inhalers 
1. ------------------------------------------------------ 
2. ------------------------------------------------------- 
3. ------------------------------------------------------- 
Name four beta-antagonists 
1. ------------------------------------------------------ 
2. ------------------------------------------------------ 
3. ------------------------------------------------------ 
4. ------------------------------------------------------ 
List five adverse effects of high does Beta-antagonists 
1. -------------------------------------------------------- 
2. -------------------------------------------------------- 
3. -------------------------------------------------------- 
4. -------------------------------------------------------- 
5. -------------------------------------------------------- 
Name two anticholinergic drugs 
1. ------------------------------------------------------ 
2. ------------------------------------------------------ 
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Which one of the above is no longer used and why? 
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------- 
 
Why should we be careful when administering oxygen to people with COPD? 
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------- 
 
Activity 6 (15 mins): To finish this section complete the table below to 
consolidate your learning about the medication and methods of 
application used to control COPD 
 
 
 
 
 
 
 
 
 
(Modified from Hough 2001)
Drug Method of delivery Side effects 
Beclomethosone  Oropharyngeal candidasis 
(thrush) 
 Oral Tachycardia (Increased 
heart rate) 
Hydrocortisone  Muscle atrophy 
Salbutamol (ventolin) Intravenous  
 Inhalation  
Ipratropium (Atrovent)  Constipation 
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This is a table showing the
 
Summary of treatments at each stage of 
COPD  
 
Mild COPD Need strong anti-smoking advice 
Few symptoms so that most will not 
even need a bronchodilator 
Moderate COPD Need strong anti-smoking advice 
Breathlessness usually sufficient to 
justify and get benefit from a single 
drug bronchodilator inhaler-unlikely to 
need combinations of bronchodilators 
Antibiotics for exacerbations 
A steroid trial useful diagnostically 
and if positive should have inhaled 
steroids  
Unlikely to require oral steroids even 
in exacerbations 
Severe COPD Very symptomatic and limited 
Will always need an inhaled 
bronchodilator and often will report 
benefit from combinations of beta-
antagonist and anticholinergic 
Subject to side effects-theophyllines 
may help 
An oral steroid trial can help selet 
patient for regular inhaled steroids 
Acute exacerbations often, severe 
requiring hospital care and oral 
steroids, antibiotics, nebulised 
bronchodilators, and sometimes 
respiratory support. Selected patients 
will need further long term support to 
maintain an acceptable quality of life 
 
(Simonds et al 1996) 
 
 
You are now equipped with all the information you need to apply this 
knowledge to the case studies, which will be provided to you via black 
board for your self managed learning (SML) session.  
 
Activity 7 (20 mins) Complete the two case studies on COPD 
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 Section 3: Pulmonary rehabilitation 
You have now discovered how medication can help manage the symptoms of COPD 
but how does physiotherapy help? This question leads us onto the subject of 
pulmonary rehabilitation, which is described as;  
 
“Pulmonary rehabilitation is an evidence based, multidisciplinary and 
comprehensive intervention for patients with chronic respiratory disease 
who are symptomatic and often have decreased daily life activities. 
Integrated into the individualised treatment of the patient, pulmonary 
rehabilitation is designed to reduce symptoms, optimize functional 
status, increase participation, and reduce health-care costs through 
stabilising or reversing systemic manifestations of the disease.” 
                  (ATS & ERS, 2006) 
 
Pulmonary rehabilitation programmes consist of a multidisciplinary team (MDT) and 
cover patient and family education; treatment of bronchospasm by means of 
bronchodilators or reduction in bronchial secretions; treatment of bronchial infections; 
treatment of congestive heart failure; oxygen therapy; chest physiotherapy including 
breathing technique training; exercise reconditioning; psychosocial therapy and 
vocational rehabilitation (Simonds et al 1996). 
 
The role of the physiotherapist 
1. A subjective and objective assessment (as taught in week 1) is carried out 
2. Identification of general and physiotherapeutic goals in collaboration with the 
MDT, patient and family 
3. Advice and education on breathing control (Sharp et al 1980 & Webber 1991) 
4. Active Cycle of Breathing Technique (ACBT) to remove secretions 
5. Thoracic mobilisations (if applicable), posture correction, transcutaneous 
electrical nerve stimulation (TENS) or stretching of muscles and ligamentous 
tissues to reduce chest wall pain due to joint dysfunction 
6. Increase functional ability through a progressive exercise programme (Toshima 
et al 1990 & Niederman et al 1991) 
 
Outcome measures 
Outcome measures such as the treadmill walking or shuttle-walking test can be used 
to determine maximum endurance. The modified BORG scale can be used in 
conjunction with one of these tests to determine the maximum level of perceived 
respiratory effort by the patient. In addition the Health Related Quality of Life (HRQL) 
questionnaire can be used as an assessment tools for a person with COPD entering 
a pulmonary rehabilitation programme. 
 
EBP 
Borg, GAV., 1982. Psychophysical basis of perceived exertion. Medical Science 
Sports Exercise. 14: 377-81 
 
Curtis, J. R. Deyo, R. A. Hudson, L. D. 1994. Health-related quality of life among 
patients with chronic obstructive pulmonary disease. Thorax. 49: 162-70 
 
Singh, S. J. Morgan, M. D. L. Scott, S. Walters, D. Hardman, A. E., 1992. 
Development of a shuttle-walking test of disability in patients with chronic airways 
obstruction. Thorax 47: 1019-24 
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 Activity 8 (30 mins): So that you can complete the activities in this 
section it is suggested that you now read chapter 14: Pulmonary 
rehabilitation: a multidisciplinary intervention: pages 471 to 488 in Pryor 
and Prasad (2004). 
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Activity 9 (40 mins): Physiotherapy assessment 
It is essential that as a physiotherapist you identify your patient’s 
individual problems before they commence pulmonary rehabilitation. 
Complete the following activity to help you to achieve this. 
 
 
Name five resources where you can obtain information about your patient that 
is available to you. 
 
1. --------------------------------------------------- 
2. --------------------------------------------------- 
3. --------------------------------------------------- 
4. --------------------------------------------------- 
5. --------------------------------------------------- 
 
 
 
What should your subjective information from your patient include? List ten 
areas that you ought to discuss with your patient. 
 
1. --------------------------------------------------- 
2. --------------------------------------------------- 
3. --------------------------------------------------- 
4. --------------------------------------------------- 
5. --------------------------------------------------- 
6. --------------------------------------------------- 
7. --------------------------------------------------- 
8. --------------------------------------------------- 
9. --------------------------------------------------- 
10. --------------------------------------------------- 
 
 
What objective information should you collect from your patient? Consider six 
and write them down in the space provided. 
 
 
1. --------------------------------------------------- 
2. --------------------------------------------------- 
3. --------------------------------------------------- 
4. --------------------------------------------------- 
5. --------------------------------------------------- 
6. --------------------------------------------------- 
 
 
Activity 10 (40 mins): Practice obtaining subjective and objective 
information from your patient by role-playing with a peer and give each 
other feedback. You might find it helpful to read pages 3 to 25 on 
assessment and investigation of patient’s problems in Pryor and Prasad 
(2004) to guide you.
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 Activity 11 (20 mins): Draw a spider diagram below to demonstrate who 
is involved in the MDT and their role within the pulmonary rehabilitation 
programme. Consider who would be included in goal setting. Don’t 
forget the patient should be at the centre! 
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Activity 12 (1 hour): Pulmonary rehabilitation programmes are set up to 
compliment rather than replace existing services for people with chronic 
disabling lung diseases such as COPD.  Complete the activity below to 
consolidate your learning on this subject. 
 
 
Think about what a routine service would offer and then consider what would 
be the fundamental components of a pulmonary rehabilitation programme and 
write them down in the space provided. 
 
1. ------------------------------------------ 
2. ------------------------------------------ 
3. ------------------------------------------ 
4. ------------------------------------------ 
5. ------------------------------------------ 
6. ------------------------------------------ 
7. ------------------------------------------ 
8. ------------------------------------------ 
9. ------------------------------------------ 
10. ------------------------------------------ 
 
 
Outcome measures 
Describe the 12-minute walking test 
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------- 
 
Describe the shuttle-walking test 
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------- 
 
Describe the modified BORG scale 
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------- 
 
Activity 14 (1 hour): During your video skills session this week, practice 
what you learnt in week 1 on giving advice and education to your patient 
on breathing control and ACBT and relate it to a COPD patient. Also 
revise your upper quadrant mobilisation techniques for thoracic pain 
and the use of TENS using a visual analogue scale (VAS) to record your 
patient’s outcome measure.
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 Section 4: CPAP / BiPAP 
You have now looked at the pathology, medication and rehabilitation programmes for 
people with COPD. This section will be taking you a step further to consider 
equipment that could benefit and support your patient. You need to be aware of how 
this equipment functions and who to refer your patient to if they start to deteriorate. At 
this stage it would be a good idea to remind yourself about the vital signs that you 
learnt in week 1.  
 
The equipment that we will discuss in this section is CPAP (Continuous Positive 
Airway Pressure) and BiPAP (Bilevel Positive Airway Pressure). Evidence 
demonstrates that they are effective in preventing intubation (a tube placed into the 
mouth to attach to a ventilator machine in intensive care) and decreasing mortality in 
patients with Acute Respiratory Failure (Kramer et al 1995, Poponick et al 1999 and 
Brochard et al 1995). 
 
CPAP 
CPAP works by delivering a continuous positive air pressure of about 10 cm of water 
throughout the respiratory system. The sensation that your patient will experience 
when using CPAP is equivalent to sticking your head out of a moving car. CPAP is 
thought to improve breathing by counteracting intrinsic PEEP (positive end expiratory 
pressure) and decreasing the work of breathing. 
 
Intrinsic PEEP 
In patients with severe COPD, the lung does not fully empty due to the obstruction in 
the airway resulting in a positive pressure in the airways at end expiration. Therefore 
for a patient with severe COPD they must initially overcome this positive airway 
pressure before a negative pressure can be generated to breathe in more air. This is 
called intrinsic PEEP and in patients with respiratory failure due to COPD it is often 
about 5cm H2O, but it can be higher. 
 
BiPAP 
BiPAP delivers CPAP but also senses when an inspiratory effort is being made and 
delivers a higher pressure during inspiration. When flow stops, the pressure returns 
to the CPAP level. This positive pressure wave during inspiration unloads the 
diaphragm decreasing the work of breathing. In patients with respiratory failure, a 
common technique is to begin with the expiratory level at 5 and the inspiratory level 
at 15. The levels are adjusted based on the patient’s comfort, tidal volume achieved 
and blood gases. 
 
 
EBP 
Brochard, L. et al 1995. Noninvasive Ventilation for Acute Exacerbations of COPD, 
NEJM. 333:817-822. 
 
Kramer, N. et al 1995. Randomized, prospective trial of noninvasive positive pressure 
ventilation in acute respiratory failure. American Journal of Respiratory and Critical 
Care Medicine, 151, 1799-1806 
  
Poponick, J. et al 1999.  Use of a Ventilatory Support System (BIPAP) for Acute 
Respiratory Failure in the Emergency Department. Chest, 116, 166-171 
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 Activity 15 (1 and half hours): Please refer to pages 175 to 181 
‘Mechanical aids’ in Hough (2001) to extend your knowledge on CPAP 
and BiPAP.  If you can complete the ‘mini case studies’ for ‘mechanical 
aids’ (p 181-182) you are well on your way to clinically reasoning a 
treatment plan for your patient.  
 
In addition you will need to know about type 1 and type 11 respiratory 
failure before reading about NPPV (non-invasive positive-pressure 
ventilation) below. I would therefore recommend that you read page 117 
in Hough (2001) to familiarise yourself with this. 
 
 
Information on NPPV  
NPPV is delivered by a nasal or face mask, therefore eliminating the need for 
intubation or tracheostomy. NPPV can be given by a volume ventilator, a 
pressure-controlled ventilator, a bilevel positive airway pressure (BiPAP or 
bilevel ventilator) device, or a continuous positive airway pressure (CPAP) 
device. Volume ventilators are often not tolerated because they generate high 
inspiratory pressures that result in discomfort and mouth leaks.  
NPPV delivers a set pressure for each breath (with a bilevel or standard 
ventilator in the pressure-support mode). Although positive-pressure support 
is usually well tolerated by patients, mouth leaks or other difficulties are 
sometimes encountered. BiPAP ventilators provide continuous high-flow 
positive airway pressure that cycles between a high positive pressure and a 
lower positive pressure.  
NPPV may be used as an intermittent mode of assistance depending on 
patients' clinical situations. Instantaneous and continuous support is given to 
the patients in acute respiratory distress. As the underlying condition 
improves, ventilator-free periods are increased as tolerated, and support is 
discontinued when the patient is deemed stable. In most studies, the duration 
of NPPV use in patients with acute on chronic respiratory failure averages 6-
18 hours. The total duration of ventilator use varies with the underlying 
disease; approximately 6 hours is used for acute pulmonary oedema and 
more than 2 days is used for COPD exacerbation.  
Honrubia et al (2005) compared the efficacy and resource consumption of 
NPPV against conventional mechanical ventilation in patients with acute 
respiratory failure. Avoidance of intubation, mortality, and consumption of 
resources were the outcome variables. Thirty-one patients were assigned to 
the non-invasive group, and 33 were assigned to the conventional group. 
NPPV reduced the need for intubation in patients with acute respiratory failure 
from different causes. A trend of reduction in intensive care units (ICUs) and 
hospital mortality together with fewer complications during ICU stay was 
observed (Honrubia et al 2005). 
NPPV and COPD 
Acute exacerbation of COPD is a frequent cause of admission to hospital and 
ICU. Patients develop a deterioration of gas exchange accompanied by rapid 
shallow breathing, severe dysponea (breathlessness), right ventricular failure, 
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and encephalopathy. The respiratory system is unable to maintain adequate 
alveolar ventilation in the presence of abnormalities in respiratory mechanics. 
Patients develop a shortened inspiratory time, decrease in tidal volume, and 
increased respiratory frequency of the excessive respiratory load. Therefore, 
treatment should be directed at reducing the loads imposed on the respiratory 
muscles.  
 
Benefits of NPPV 
 
In acute respiratory failure, NPPV offers a number of potential advantages 
over invasive positive pressure ventilation (PPV). These advantages include 
the avoidance of intubation-related trauma, a decreased incidence of 
nosocomial pneumonia, enhanced patient comfort, a shorter duration of 
ventilator use, a reduction in hospital stay, and ultimately, reduced cost.  
 
Mechanisms of action 
 
NPPV decreases the work of breathing and thereby improves alveolar 
ventilation while simultaneously resting the respiratory musculature. The 
improvement in gas exchange with BiPAP occurs because of an increase in 
alveolar ventilation. Externally applied expiratory pressure (eg, positive end-
expiratory pressure [PEEP]) decreases the work of breathing by partially 
overcoming the auto-PEEP, which is frequently present in these patients. The 
patients generate a less negative inspiratory force to initiate a breathing cycle. 
  
Inhalation and exhalation
  
In spontaneous mode, upon detection of inspiration, higher pressure is 
delivered until the flow rate falls below the threshold level. The expiratory 
pressure with bilevel pressure support is equivalent to the PEEP, and the 
inspiratory pressure is equivalent to the sum of the PEEP and the level of 
pressure support. In timed mode, biphasic positive airway pressure ventilation 
alternates between the inspiratory and expiratory pressures at fixed time 
intervals, which allows unrestricted breathing at both pressures. This differs 
from the spontaneous mode of BiPAP, which cycles on the basis of the flow 
rates of the patient's own breathing.  
Supplemental oxygen can be connected to the device, but a higher flow of 
oxygen therapy is usually required.  
NPPV is more effective in a relaxed patient and is not optimal in an anxious 
uncooperative patient or a patient fighting the ventilator. Patients must be 
adequately prepared with properly fitting masks, and the increase of the 
inspiratory and the expiratory pressures should occur gradually. Effectiveness 
should be determined clinically by improved respiratory distress, decreased 
patient discomfort, and improved results from arterial blood gas 
determinations. 
N/B You will learn about arterial blood gases in week 3. 
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Clinical trials supporting the use of NPPV in patients with COPD 
exacerbation 
 
NPPV is an effective means of treating patients with acute respiratory failure 
resulting from a variety of causes, as demonstrated by uncontrolled studies 
and prospective randomized trials. NPPV improves alveolar ventilation by 
increasing tidal volume. Most studies have used NPPV as an intermittent 
mode of support because the support is not delivered on a continuous basis, 
but rather for 6-18 hours per day. The duration of NPPV depends on each 
patient's clinical situation.  
Most trials used inspiratory pressures of 12-20 cm water and expiratory 
pressures of 0-6 cm water and excluded patients with hemodynamic 
instability, uncontrolled arrhythmia, or a high risk of aspiration.  
Recent prospective randomized studies strongly support the use of non-
invasive mechanical ventilation in patients with severe exacerbations of 
COPD. In a large randomized trial (Brochard 1995) comparing NPPV with a 
standard ICU approach, the use of NPPV was shown to reduce complications, 
the duration of ICU stay, and mortality. Patients in whom NPPV failed had a 
similar mortality rate compared to the intubated group (25% vs 30%).  
Wysocki and colleagues (1995) recently published the largest prospective 
randomized study comparing NPPV to standard treatment in patients with 
COPD exacerbation. NPPV was administered on the ward; the nurses were 
trained for 8 hours in the preceding 3 months. Treatment failed in significantly 
more patients compared to the control group (27% vs 15%); in-hospital 
mortality rates were significantly reduced from the use of NPPV (20% to 
10%).  
In addition, 3 Italian cohort studies with historical or matched control groups 
have suggested that long-term outcome of patients treated with NPPV is 
much better than that of patients treated with medical therapy and/or with 
endotracheal intubation.  
Cochrane Systematic Review determined the efficacy of NPPV in the 
management of patients with respiratory failure due to an acute 
exacerbation of COPD.  
Fourteen studies were included in the review. NPPV resulted in decreased 
mortality (relative risk [RR] 0.52), decreased need for intubation (RR 0.41), 
and reduction in treatment failure (RR 0.48). The complications associated 
with treatment (RR 0.38) and length of hospital stay (mean, 3.24 d) was also 
reduced in the NPPV group. NPPV has benefit as first-line intervention in 
addition to usual medical care in all appropriate patients for the management 
of respiratory failure secondary to an acute exacerbation of COPD. Early 
NPPV is known to reduce the likelihood of endotracheal intubation, treatment 
failure, and mortality (Ram 2004).  
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Early use of NPPV to assess the outcomes of acute exacerbation of COPD 
was evaluated in those patients with respiratory muscle fatigue and mild 
respiratory insufficiency. The early use of NPPV on general ward improved 
arterial blood gas and respiratory pattern and decreased the rate of need for 
intubation in patients with acute exacerbation of COPD.  
Severely altered level of consciousness (ALC) has been considered a 
contraindication to NPPV. A recent study compared the clinical outcome of 
patients with acute respiratory failure due to COPD exacerbations and 
different degrees of ALC. This study confirmed that NPPV was successfully 
applied to patients experiencing COPD exacerbations with milder ALCs, 
whereas the rate of failure in patients with severely ALCs was higher, but an 
initial and cautious attempt with NPPV may be performed (Scala 2005).  
A step-wise approach to the management of acute COPD exacerbation 
 
A summary of all these studies shows that NPPV has been shown to offer 
better outcomes to patients admitted with acute exacerbations of COPD. A 
complimentary step-wise approach to these patients is recommended:  
 
1. The first step is based on medical care with drug treatment and oxygen 
supplementation.  
2. The second step is the early use of NPPV to prevent further worsening 
of the COPD and subsequent clinical deterioration. NPPV should be 
delivered to patients who have respiratory distress and develop 
moderate respiratory acidosis, ie, a pH of less than 7.30. NPPV should 
also be offered to the patients in whom medical therapy has failed, 
whose ventilatory function deteriorates, and those who are candidates 
for ventilatory assistance.  
3. The final step is endotracheal intubation and mechanical ventilation. 
This should be reserved for patients who deteriorate despite NPPV or 
patients in whom NPPV is contraindicated. 
The use of NPPV does not require longer nursing time, but longer respiratory 
therapist time is required in the initial period 
Patient selection 
Patients who are in acute respiratory distress and are at risk of needing 
intubation should be selected for non-invasive ventilation if they have a 
reversible cause of acute respiratory failure. 
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Guidelines for the use of NPPV in patients with acute respiratory failure 
1. Blood gas findings 
a) Partial pressure of carbon dioxide in arterial gas (PaCO2) 
greater that 45mm Hg 
b) PH less than 7.35 but more than 7.10 
c) PaO2 and fraction of inspired oxygen (FIO2) less than 200 
 
2. Clinical inclusion criteria 
a) Signs or symptoms of acute respiratory distress 
b) Moderate-to-severe dyspnoea, increased over usual 
c) Respiratory rate greater than 24 breaths per minute 
d) Accessory muscle use 
e) Abdominal paradox 
f) Gas exchange 
g) PaCO2 greater than 45 mm Hg and PH less than 7.35 
h) PaCO2 to FIO2 ratio less than 200 mm Hg 
3. Diagnosis 
a) COPD exacerbation 
b) Acute pulmonary oedema 
c) Pneumonia 
4. Contraindications 
a) Respiratory arrest 
b) Inability to use mask because of trauma or surgery 
c) Excessive secretions 
d) Haemodynamic instability or life-threatening arrhythmia 
e) High risk of aspiration 
f) Impaired mental status 
g) Uncooperative or agitated patient 
h) Life-threatening refractory hypoxemia (alveolar-arterial 
difference in partial pressure of oxygen (PaO2) < 60 mmHg with 
FIO2 of 1) 
5. Factors predictive of success 
a) Younger age 
b) Lower acuity of illness (ie, acute physiology and chronic health 
evaluation (APACHE) score) 
c) Patient able to cooperate 
d) Ability to coordinate breathing with ventilator 
e) Moderate hypercapnia (PaCO2 > 45 mm Hg but <92 mm Hg) 
f) Moderate academia (PH>7.10 but <7.35 
g) Improvement in gas exchange and heart and respiratory rates 
within first 2 hours 
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Protocol for initiation of NPPV in patients with acute respiratory failure 
1. Position the head of the bed at a 45 degree angle 
2. Choose the correct size of mask and initiate ventilator at CPAP 
(expiratory positive airway pressure or EPAP) of 0cm water with 
a pressure support of 10 cm water 
3. Hold the mask gently on the patient’s face until the patient is 
comfortable and is full synchrony with the ventilator 
4. Apply wound care dressing on the patient’s nasal bridge and 
other pressure points 
5. Secure the mask with head straps, but avoid a tight fit 
6. Slowly increase CPAP to more than 5 cm water 
7. Increase pressure support (i.e. inspired positive airway pressure 
or IPAP, 10-20 cm water) to achieve maximal exhaled tidal 
volume (10-15 mL/Kg) 
8. Evaluate that ventilatory support is adequate, which is indicated 
by an improvement in dysponea, a decreased respiratory rate, 
achievement of desired tidal volume and good comfort for the 
patient 
9. Oxygen supplementation is achieved through NPPV machine-to-
machine oxygen saturation of greater than 90% 
10. A backup rate may be provided in the event the patient becomes 
apeneic 
11. In patients with hypoxemia, increase CPAP in increments of 2-3 
cm water until FiO2 is less than 0.6 
12. Set the ventilator alarms and backup apnoea parameters 
13. Ask the patient to call for needs, and provide reassurance and 
encouragement 
14. Monitor with oximetry and adjust ventilator settings after 
obtaining arterial blood gas results 
Weaning from NPPV 
In stable patients, weaning from NPPV may be accomplished either by 
progressively decreasing the levels of positive airway pressure or by 
discontinuing the therapy for increasing lengths of time. A combination of both 
strategies can also be used. 
 
Severe but stable COPD  
Evidence for the use of NPPV in patients with severe but stable COPD is less 
convincing. Enthusiasm was initially generated in the 1980s by the hypothesis 
that the intermittent use of negative-pressure ventilation in patients with 
severe but stable COPD would improve overall function by resting chronically 
fatigued respiratory muscles. Subsequent controlled studies have 
demonstrated no significant benefit.  
Of the 4 controlled studies using NPPV for severe but stable COPD, only 1 
has shown favourable results. This crossover study by Meecham Jones 
(1993) used a nasal BiPAP system nocturnally, and improvements were 
observed in daytime and nocturnal PaCO2, total sleep time, and quality-of-life 
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scores after 3 months of NPPV use. Patients enrolled in this study had an 
average PaCO2 of 57 mm Hg and an FEV1 of 821 mL. Many patients with 
severe chronic COPD do not tolerate long-term PPV.  
A trial of nocturnal NPPV is recommended in patients with COPD with severe 
hypercapnia (PaCO2 >55 mm Hg), nocturnal oxygen desaturation, coexisting 
sleep disordered breathing, and possibly patients with frequent panic attacks, 
which may be relieved by using NPPV. 
(Modified from Sharma 2006) 
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Activity 16 (30 mins): Revise your work from week 1 on partial pressures 
and then write down all the millimetres of mercury (mm Hg) values that 
you can find in the above information. Now convert the readings into 
kilopascals (kPa). This is a useful exercise as kPa is now widely used in 
hospitals instead of mm Hg. 
 
1 kPa = 7.5 mmHg 
 
Example:  
Paco2 4.5-6 kPa (35-50 mm Hg)  
Pao2 11-14 kPa (83-105 mm Hg)  
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Activity 17 (20 mins): Write down in the space provided when BiPAP and 
CPAP should be administered 
 
 
 
 
 
 
 
 
 
 
Activity 18 (30 mins): Make a list of the words in the information on 
NPPV that you don’t know and find out their meaning using a medical 
dictionary 
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 Section 5: Psychosocial 
We now need to consider our patient as a person and how that person is feeling with 
the diagnosis of COPD. Viewing our patient holistically will help us to provided a 
better service for people with COPD. If we can relate to the emotions that a person is 
going through we will also comprehend how it is affecting them mentally as well as 
physically. With this knowledge you will begin to realise why treating someone with 
COPD can be both challenging and rewarding as well as accepting why at times they 
are non-compliant (rebellious) to treatment.  
 
How can physiotherapy help? 
Physiotherapy can help reduce feelings of stress and anxiety and prevent problems 
such as hyperventilation and depression. There are a number of ways in which this 
can be done for example through; 
 
• Listening to your patient’s fears and anxieties 
• Relaxation techniques 
• Advice and education 
• Progressive exercise programmes (hospital and home based) 
• Breathing control 
• Setting goals with the patient and their family 
• Energy conservation, e.g. life style changes, pacing 
• Maintaining good posture and gait (walking) pattern 
• Reducing pain through Postural advice and the use of TENS 
• Removing secretions 
 
Getting your patient to mobilise (walk) is really important to maintain their functional 
activities of daily living (ADL). This simple but effective activity will also aid the 
clearance of secretions and improve your patient’s respiratory capacity.  
 
People with COPD often get into a vicious cycle of becoming frightened to move, so 
they remain immobile, which reduces their exercise tolerance and therefore 
increases their breathlessness when they do attempt to get to the toilet for example. 
The latter increases their fear of becoming more breathless and they become 
increasingly dependant and less active. Their social life stops because of this and 
soon they find themselves isolated. As they lose control of the situation their self-
esteem is lowered and this is often when depression sets in. At this point it becomes 
a challenge to motivate your patient. You therefore need to treat your COPD patients 
at the earliest possible opportunity to prevent this vicious cycle from occurring. 
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 Activity 20 (20 mins):
 
So that you will be better equipped to clinically 
reason an individual treatment plan we will be bringing in a person with 
COPD so that you can talk to them. This person will have attended a 
patient support group (PSG) so you will be able to find out more about 
the benefits of people attending such groups.  You can also find out 
their experiences of physiotherapy and pulmonary rehabilitation (if they 
have had this service available to them). It is suggested that you read 
the following to increase your knowledge in this subject before coming 
to the patient panel. 
 
 
COPD as a Stressful Life Event 
Chronic illness demands continual psychological adjustment as the disease 
progresses through different stages from no symptoms to mild, then moderate 
and severe symptoms. Respiratory patients must cope with a wide variety of 
stressors including: shortness of breath, cough, sputum production, wheeze, 
pain, changing body image, loss of independence, social stigma, social 
isolation and uncertainty about the future. 
 
Along with these respiratory associated stressors COPD patients must also 
deal with changing environments, family pressures and other critical events 
that occur during this time of their life span. Although successful adaptation to 
the disease process (and critical life events) is normal, adverse psychological 
reactions can commonly occur at some time during the chronic disease 
process. Such reactions include - depression, anxiety/worry, panic attacks, 
irritability and confusion. 
 
The word stress can be confusingly used to mean two different things. 
Sometimes the word stress is used to describe a stressor. A stressor is 
something that people perceive as a threat and that calls upon the individuals 
coping mechanisms. They include situations that cause uncertainty or where 
people feel a lack of control, or harmful or unpleasant situations that lead to 
stressful reactions (eg. "giving that presentation was very stressful"). 
 
At other times stress can be taken to mean the stress reactions that occur in 
response to the stress such as thoughts, feelings, behaviours and 
physiological responses (e.g. showing "signs" of stress). 
 
Therefore stress is a process that can be seen as an interaction between the 
coping skills of the individual and the demands of his/her environment. The 
following account will use the 3-part stress model to try and explain some of 
what patients may experience and how PSG may help. 
  
 
Physical and Psycho-social Stressors 
 
As previously defined stressors are situations that put demands on coping 
skills. The COPD patient comes into contact with and must cope with a wide 
variety of physical stressors which include shortness of breath and other 
respiratory symptoms, environmental pollution, changes in temperature, 
exposure to infection/disease, taking medication and hospitals/medical clinics. 
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As we all live and function in a social context these attributes of our 
environment (psycho-social stressors) can also put demands on our ability to 
cope. The COPD patient must be able to manage the chronic disease while 
still trying to maintain effective relationships with their spouse, friends, 
acquaintances and health care staff. However, due to the disabling nature of 
the disease it can cause relationships to be strained and may result in many 
patients being socially isolated and not seeking treatment. 
One of the aims of PSG's is to empower patients with better coping skills to 
deal with both the physical and psycho-social stressors. This can be achieved 
through encouraging patients to help each other and presentations from guest 
speakers to reinforce what they have already learned in pulmonary 
rehabilitation. 
Psychological Stress Reactions 
 
The psychological responses that COPD patients have to stress include the 
thoughts, feelings and concerns they have about their perceived threats. 
These are their interpretation of the situation and each patient can interpret 
the same situation in a different way. Such expectations of coping can 
become distorted in COPD as they may be based on past experiences in 
which patients did not cope well. Examples of some distorted and unrealistic 
interpretations include "This attack is going to become severe", "I'll end up in 
hospital," "I can't do anything any more because I get short of breath," "I'm a 
useless individual", "My life is not worth living." 
These thoughts can lead to negative feelings such as anxiety, anger, tension, 
frustration, hopelessness and depression. In fact, two Australian based 
studies (including the Australian Lung Foundation) and other studies have 
shown that there is a significant prevalence of psychiatric morbidity in COPD. 
The prevalence of depression and anxiety in COPD can range between 40 - 
90% compared to 8 - 20% in the normal population. 
Such psychological disturbance can compound the disability and handicap 
faced by people with COPD, leading them to withdraw from life, becoming 
more socially and physically inactive which in turn enhances the psychological 
symptoms and a vicious cycle appears. 
PSG's can give patients the opportunity to discuss their feelings and emotions 
(which in itself is extremely therapeutic) as well as physically getting out and 
participating in activities which are both enjoyable and rewarding. This type of 
treatment (support groups which incorporate activity) has been shown in 
clinical trials to be effective in alleviating anxiety and depression. The 
Australian Lung Foundation randomised control rehabilitation trial showed that 
small group rehabilitation and support significantly reduced psychiatric 
morbidity in the COPD sample. 
Sedentary lifestyles can lead to deconditioning of muscles and reduced 
fitness. Many patients with COPD develop a phobia towards exercise due to 
shortness of breath, embarrassment, misinformation, anxiety and depression 
and a vicious cycle of inactivity can occur.  
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PSG's can provide an environment that encourages people to participate in 
physical exercise and also provide exercise classes. They can also 
encourage people to be more physically active by organising walks and tours 
for its members. 
Another aim of PSG's is to change/modify the way people think about their 
disease. They may endeavour to change and replace the defeatist and 
negative attitudes and thoughts exhibited by many patients with a more 
positive outlook. Changing the way people think about their situation has been 
shown to effect the way they feel and thus we may be able to alleviate some 
of the feelings of depression, anxiety and hopelessness.  
Physiological Responses to Stress  
The body reacts to stress through a variety of physiological responses which 
include: Increases in heart rate, blood pressure, blood flow, tension in 
voluntary muscles, perspiration, depth and frequency of breathing and 
nausea, diarrhoea, hot flushes, cold chills. 
This represents the body's attempt to adapt to the increased load of coping 
with the stressor. It is the automatic self-protection mechanism (termed the 
"Fight or Flight Response") that prepares the body to fight the threat or avoid 
it. 
In some instances these physiological responses can be misinterpreted or not 
dealt with soon enough and they can become out of control leading to a panic 
attack. As the precipitant of a panic attack is usually shortness of breath it is 
not surprising that many COPD patients suffer from such attacks. 
Although strategies for coping with panic attacks are discussed during 
pulmonary rehabilitation, PSGs afford the opportunity to reinforce some of 
these strategies (e.g. diaphragmatic breathing, relaxation techniques) through 
practice and discussion. 
 
What happens when the stress response continues?
 
Stress is a three-stage process 
1. The Alarm Phase - the initial response of the body (i.e. the flight or fight 
response). Little thought involved  
2. Stage of Resistance - Coping and Adaptation  
3. Stage of Exhaustion - Shock and Lowered Resistance to Infection  
If the stage of resistance (coping and adaptation) is not effectively performed 
this can lead to several psychological changes which include alteration in 
personality and cognition e.g. 
• Increased difficulty in solving problems, worry excessively, misinterpret 
situation, irritability, easily frustrated, lack of energy, loss of interest, 
forgetful, insomnia, fear loss of control 
• More aggressive – complain about care, become more demanding, 
argumentative, stubborn, stressful situations are increasingly avoided 
• More passive – difficulty in making decisions, becomes increasingly 
isolated, waits to be taken care of 
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As a result of their COPD many patients have reduced oxygen levels in their 
blood stream. Oxygen is required by the brain in order for it to function 
properly and significantly reduced oxygen levels can cause deficits in short 
term memory, planning and organisation and concept formation. When this is 
accompanied by the cognitive problems associated with stress, it is not 
surprising that in a study, which was recently conducted by the Australian 
Lung Foundation, 81% of the COPD sample exhibited some form of cognitive 
deficit. 33% showed visual short-term memory impairment and 44% verbal 
short-term memory impairment. Therefore ongoing PSG's provide an 
opportunity to rehearse and review learned material and therefore enhance 
learning. 
 
The more coping skills COPD patients can use, the more likely it is that they 
will be able to MAINTAIN, CONTROL AND COPE EFFECTIVELY with their 
disease and reduce the chances of psychological and cognitive disturbance. 
 
Another psychological benefit of PSG's is that many patients’ feelings of 
isolation and having to cope alone are ameliorated through social comparison. 
Patients are relieved, know that they are not the only ones with respiratory 
disease problems and that there are others who are just as sick as them, and 
have similar problems. Many of the patients view PSG's as self-help groups 
where they learn how to cope through listening to what others have done. 
 
Summary
 
PSG's provide the ideal opportunity for COPD patients to learn how to cope 
more effectively by providing information, social comparison, reinforcement, 
encouragement and support in a caring environment, alleviating fears and 
anxieties, providing pleasurable and enjoyable activities and changing the 
way people think about their disease. Such interventions are aimed at 
decreasing depression and anxiety, improving quality of life and reducing 
length of stay and hospital admissions. 
  
   
© 2000, The Australian Lung Foundation (modified for this workbook) 
 Bournemouth University COPD workbook: Caroline Belchamber: September 
2008 
45
Notes 
 Bournemouth University COPD workbook: Caroline Belchamber: September 
2008 
46
 Activity 21 (30 mins):
 
Now that you have read about psychosocial 
aspects of COPD see if you can identify problems that your patient’s 
might present. Consider the effect on your patient’s mobility and 
functional impairment and write your list in the space below. 
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 Activity 22 (20 mins): Now you are ready to consider what questions you 
would like to ask the person with COPD attending the patient panel. 
Please use the space below to write down your questions.
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Section 6: Case study 
In this section you will draw together all that you have learnt in chapter two 
and during week 2 of the cardio respiratory unit to clinically reason the 
following case study. This will help you towards achieving your video-critique 
assessment for the cardio respiratory unit;  
 
 
 
Activity 23 (1 hour): A 56 year-old man has been admitted to hospital 
with an acute exacerbation of COPD. He has been referred to you for 
respiratory physiotherapy and advice. This is his second admission in a 
year. He was diagnosed with COPD two years ago. He has noticed that 
his exercise tolerance is deteriorating and he is finding it increasingly 
difficult to cope with his job as a builder. He is anxious about his 
finances as he has a mortgage to pay and a family to support (he is the 
main earner). He has also attempted to give up smoking but he says he 
struggles with this as it helps him to relax and causes him to cough, 
which “gets rid of the phlegm”.  
 
Remember to use SMART goals (refer back to your previous work on 
problem orientated medical records (POMR) and EBP when clinically 
reasoning your treatment plan for the this patient. 
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 Well done you have completed the workbook on COPD and you now 
have a solid knowledge base to help you to produce your product for 
week 2. This will also be enhanced with your own individual learning 
from the trigger at the beginning of the week. You can now progress to 
the next workbook and continue to build on your knowledge in 
respiratory physiotherapy. 
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